| 1) | Miyake S:Potential of targeting natural killer T cells for the treatment of autoimmune diseases. The innate immune system: Strategies for disease control Taniguchi M, Akira S, Nakayama T, eds, Elsevier, Amsterdam, 189-91 2005 |
| 2) | Chiba A, Miyake S:NKT cells in models of arthritis. The immuno-regulatory role of natural killer T cells in inflammatory disease Croxford JL, eds, Signpost, Kerala, 71-85, 2005 |
| 3) | Oki S, Miyake S:Molecular basis of differential cytokine production by glycolipid ligand-stimulated natural killer T (NKT) cells for therapeutic interventions for inflammatory autoimmune disease. The immuno-regulatory role of natural killer T cells in inflammatory disease Croxford JL, ed, Signpost, Kerala, 159-74, 2005 |
| 4) | Miyake S:Invariant NKT cells in autoimmunity. Current Topics in Neuroimmunology Tabira T, Yamamura T, Kira J, eds, Medimond, Bologna, 91-5 2006 |
| 5) | Miyake S, Yamamura T:NKT cells and Autoimmune Diseases: Unraveling the complexity. Current Topics in Microbiology and Immunology Moody DB, ed, Springer-Verlag, Heidelberg, 251-65 2007 |
| 6) | Sakuishi K, Miyake S, Yamamura T:Role of NKT cells in multiple sclerosis: In a quest to understand and overcome their highly efficient double edged swords. Molecular Basis of Multiple Scoerosis. The Immune System Series "Results and Problems in Cell Differentiation" Gramm U, ed, Springer-Verlag, Heidelberg (in press) |